MINERVAX ApS: Financial statements 2019
CVR: 32673287
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -25,879,062 and a net result of DKK -24,795,628 compared with DKK -11,497,359 the year before. Equity in the 2019 report amounted to DKK -29,683,660. The company had 1 employee in the financial year.
- Gross Profit
- DKK -25,879,062
- Profit/Loss
- DKK -24,795,628
- Equity
- DKK -29,683,660
- Total Assets
- DKK 21,493,712
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -25.9 mio. | -24.8 mio. | -29.7 mio. | 1 |
| 2018 | - | -12.1 mio. | -11.5 mio. | -4.9 mio. | 1 |
| 2017 | - | -6 mio. | -4.9 mio. | 6.6 mio. | 2 |
| 2016 | - | -20 mio. | -17.4 mio. | 11.5 mio. | 3 |
| 2015 | - | -15.6 mio. | -13.1 mio. | 413 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
MINERVAX ApS has published its annual report for 2018. Gross profit came to DKK -12,098,303, and the net result was DKK -11,497,359.
As of April 5, 2019, Mona Annelie Sylvén Troedsson has left the board of directors of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees (2018). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.